1. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases;Irani;Mol. Immunol.,2015
2. US Biosimilars Market Size to Reach $22,996 Million by 2027; Recent Scientific Discoveries Have Indicated Signs of a Promising Future, Says Fortune Business InsightsTM;Business Insights,2020
3. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars;Berkowitz;Nat. Rev. Drug Discov.,2012
4. Scientific considerations in demonstrating biosimilarity to a reference product guidance for industry scientific considerations in demonstrating biosimilarity to a reference product. Quality considerations in demonstrating biosimilarity of a therapeutic P;US;Cent. Drug Eval. Res.,2015